Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4297146 | Journal of Gastrointestinal Surgery | 2006 | 9 Pages |
Abstract
Pancreatic cancer has a poor prognosis with complete surgical resection being the only therapy to offer a realistic chance for long-term survival. The aim of this study is to identify surgery-related variables that influence long-term survival. Between 1990 and 2002, 226 consecutive patients (mean age of 64 ± 11 years) had resection for pancreatic adenocarcinoma. Prognostic variables in these patients were analyzed using univariate and multivariate analysis. Two hundred four patients (90%) had pancreaticoduodenectomy, 13 patients (6%) had distal pancreatectomy, and 9 patients (4%) had a TP. Stage I disease was present in 50 (22%), stage II disease in 170 (75%), and stage III disease in 6 (3%). R0 resections were achieved in 70%. Operative morbidity was 36% and 30-day mortality was 6%. Actual 1-year, 3-year, and 5-year survival rates were 49% (n = 111), 14% (n = 31), and 4% (n = 9). Using multivariate analysis: tumor size, tumor differentiation, obtaining an R0 resection, and lack of postoperative complications were variables associated with long-term survival. Long-term survival in patients with pancreatic cancer after resection remains poor. Achieving a margin negative resection (R0) with no postoperative complications are prognostic variables that can be affected by the surgeon.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Thomas J. M.D., Joseph E. M.D., Jian M.S., Nick J. M.D., C. Max M.D., Lewis E. M.D., James A. M.D., Eric A. M.D., Keith D. M.D.,